chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 2/9/2023, I had a runny nose and sore throat. I was on a cruise at the time. On 2/10/2023, I continued to get sicker with a very runny nose, body aches, and fatigue. I flew home that day. I was so out of breath that it took me an hour to walk from the plane to the shuttle at the airport, because I kept stopping on account of being out of breath. I threw up once that day. I woke up very sick the morning of 2/11/2023. I did a home antigen test, which immediately yielded a positive result. I then called my doctor, who prescribed me PAXLOVID, which I began taking on 2/12/2023. The runny nose, sore throat, and fatigue lasted for maybe ten days. The PAXLOVID left a foul taste in my mouth. I then felt better on 2/14/2023 and 2/15/2023, only to develop strep throat subsequently. I tested positive for strep throat on 2/25/2023. I had assumed that the symptoms of what I now know to be strep throat were just a continuation of the COVID-19. It took about twelve days for me to recover from the strep throat. On 2/25/2023, I was given a rapid test for COVID-19, and the result was negative. At the time of this writing, I'm doing fine, except I'm having trouble sleeping at night. I don't think it's COVID-19 related, but I do think that my illnesses may have thrown off my sleep cycle.
fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In October 2023, the patient experienced FATIGUE (fatigue). At the time of the report, FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-745830, US-MODERNATX, INC.-MOD-2023-745834 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-745830:Husband case for previous dose (SPIKEVAX NOS ) US-MODERNATX, INC.-MOD-2023-745834:Husband case for recent dose (SPIKEVAX 2023-2024)
Severe shoulder and back pain. Loss in range of motion in left shoulder. Unable to raise arm above head. Unable to turn to neck to either side. Pain recedes and comes back within a few days.
Developed a huge rash at injection site; Itchy rash; swollen glands; 103.7 fever; nauseous; pain in head; Delirium; confusion; couldn't get out of bed i had no known coverage; Ear hurt; Throat hurt; weak; Migraine; sweating; Vein burst in left wrist and stomach; This spontaneous case was reported by a consumer and describes the occurrence of DELIRIUM (Delirium) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Broken bones and Surgery. Concurrent medical conditions included Neck pain. Concomitant products included OXYCODONE from 05-Jan-2021 to an unknown date for Neck pain.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced DELIRIUM (Delirium) (seriousness criterion medically significant), CONFUSIONAL STATE (confusion), MOBILITY DECREASED (couldn't get out of bed i had no known coverage), EAR PAIN (Ear hurt), OROPHARYNGEAL PAIN (Throat hurt), ASTHENIA (weak), MIGRAINE (Migraine), HYPERHIDROSIS (sweating), VASODILATATION (Vein burst in left wrist and stomach), LYMPHADENOPATHY (swollen glands), PYREXIA (103.7 fever), NAUSEA (nauseous) and HEADACHE (pain in head). On 31-Jan-2021, the patient experienced RASH PRURITIC (Itchy rash) and INJECTION SITE RASH (Developed a huge rash at injection site). On 05-Feb-2021, MOBILITY DECREASED (couldn't get out of bed i had no known coverage) had resolved with sequelae, INJECTION SITE RASH (Developed a huge rash at injection site) had resolved. At the time of the report, DELIRIUM (Delirium), CONFUSIONAL STATE (confusion), EAR PAIN (Ear hurt), OROPHARYNGEAL PAIN (Throat hurt), ASTHENIA (weak), MIGRAINE (Migraine), HYPERHIDROSIS (sweating), VASODILATATION (Vein burst in left wrist and stomach), LYMPHADENOPATHY (swollen glands), PYREXIA (103.7 fever), NAUSEA (nauseous) and HEADACHE (pain in head) was resolving and RASH PRURITIC (Itchy rash) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 103.7.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment information was not provided.   This case was linked to MOD-2021-280549 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Upon follow-up receipt: New events were added. Product second dose added, Concomitant medication information added. Patient demographics added.
I had a fever and so I tested and was positive for COVID-19. I had just gotten back from being at a college campus. I had a slight headache and cough, then fatigue. There was a day before I got better that I had shortness of breath. The number one symptom was fatigue that persisted after testing negative. Late October I had a really bad cough and was diagnoses with bronchitis. I went to urgent care as a result of this and was tested for COVID-19 and was negative. I'm better now and haven't tested positive with COVID-19 since that August.
Pt received first dose of Moderna.  While in waiting area she became lightheaded and had a syncopal episode.  911 was called and pt transported to hospital.
routine testing done, resident first negative, then became symptomatic with respiratory issues, sent to hospital where he  tested positive.
pt recvd vax;sterile abscess or possible cellulitis;severe inject site rxn of swelling & erythema;tx keflex & ice packs;
Client registered for J&J appointment and incorrectly reported they were 18 years old or older. This was not caught in screening, and incorrect dose of Janssen was given.
This spontaneous report was received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On an unknown dates in 2017 (reported as beginning sometime in January 2017), the patients were vaccinated with improperly stored doses of VAQTA (lot # M033611, expiration date: 02-MAR-2018)(dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of  93.04 degrees Fahrenheit for 8 hours and 42 minutes on 24-JAN-2017. Data logger was not involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1703USA012513: US-009507513-1703USA012514: US-009507513-1703USA012512:
Had shot  9/15/22 at approx 520pm. By 630p was noticing an odd smell, by 7p it seemed to smell like burning hair. Occurred intermittently until bedtime at 10p  On 9/16 noticed I still experienced the smell but less frequently. No loss of smell or taste. This did not happen with any of my three prior Moderna vax shots Notified pharmacist at approx 12 noon 9/16  Note: this is an initial report based on <24h following vaccine. Will update with any changes or additional information and duration of side effect(s)
Sudden onset of Raynaud's Disease Erectile Dysfunction Anus itch Hair Loss
Pt in (w/ mom and grandmother) for a Tdap vaccine on nursing schedule (needed early for camp) at 11:30AM. Tdap was administered while pt was sitting in upright position on bed. Nurse left pt sitting on bed in room with mom and grandma. Nurse came back after 5 minutes and was speaking with mom while pt was sitting on bed. At about 11:45AM Pt stood, lost consciousness, and fell forward. She hit her head on wall and chair, splitting her chin open. At no point did the patient complain of weakness or dizziness. 2 MDs arrived within 5-10 seconds. Pt was arousable after about 30 seconds, was A&Ox3. Care was taken over by MD. Pt was monitored in the office for about 1.5hrs then sent to ED for stitches.
Sudden sensorineural hearing loss in left ear, facial numbness, tinnitus starting 4/27/19. Patient seen in our office 4/29/19 with confirmatory audiogram showing severe left hearing loss, loss of discrimination. Started on Valtrex, prednisone 60mg daily, and lipoflavinoid supplements. Subsequent audiiogram 5/3/19 showed no improvement.  MRI of brain and internal auditory canal show no lesions.
Narrative: Pt has hx of recent abnormal menses after COVID vaccine. She had this occur after the vaccination course. Was placed on norethindrone for a short period of time and this resolved the issue. She recently received the booster and again had a repeat of irregular menses. She is needing a short course of norethindrone again. Please note that patient received all vaccine doses outside of facility. Exact timing of adverse event unknown, but system would not let me submit without entering a date in the event field.
I was biking home from work (which I usually do 1-3 times per week) and about 3-5 minutes into the ride I started feeling worse than I usually do biking (more short of breath, more tired, more chest tightness, harder to breathe, a lot of mucus in my throat, much more painful in my throat). At about 15 minutes in I was really coughing a lot and it felt very hard to breathe and I had a very sharp pain in my throat, like the muscle was spasming. The ride was about 20-30 min. I was alternating between coughing and gasping for air when I got home. I laid down but that made it harder to breathe so I stood back up. It was difficult to talk because I couldn't get enough air. I thought maybe I had developed exercise-induced asthma since it was the first time it was colder out so I went to the urgent care who sent me to the ER. I started feeling anxious and I was hyperventilating, which I think made me feel dizzy and tingly in my hands and legs. By the time I was there at the ER, I had started to feel better, and by the time I was admitted I felt completely better except for some lingering chest tightness and sore throat which I think was from the coughing - that lasted about 48 hours. Now I feel completely better, but I haven't tried biking again so I'm not sure if this is something that would happen again.
Patient received vaccine on 10/5/11. The following day the patient noticed the development of a bruise on the lower left forearm of same arm as vaccine. Did not note of any trauma that would cause such a bruise. After 7 days, bruise resolved and no lasting effects.
redness, pain swelling, warmth, itching @ site p/dose 1 & 2;
Information has been received from a registered nurse concerning a 72 year old female with mitral valve prolapse, hypertension, arthritis, hypercholesterolaemia and ACCUPRIL allergy and a history of subthyroidectomy who on 27-JUN-2008 was vaccinated with a dose of ZOSTAVAX (lot #659615/0162X). Concomitant therapy included ezetimibe (MSD), propanolol HCl, LOPID, digoxin, PREMARIN, ACCUPRIL, diazepam, SULAR. The nurse reported that the patient developed a 5.5 by 5.5 inch erythemous pruritic rash at the injection site after administration of ZOSTAVAX. The patient stated the area was sore. The patient's vital signs were normal. In follow-up information the nurse reported that the patient had itchy body aches. The nurse reported that on 13-JUL-2008, spoke with the patient and she stated that the reaction had completely subsided within 5 days and had a further problems. The nurse reported that the patient's husband had had shingles for weeks prior the patient's vaccination. At the time of the report the patient has recovered. The patient sought medical attention. No further information is available.
feeling dizzy; Tired; Headache; This is a spontaneous case from a contactable consumer (patient, self-reported). A 46-Year-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EM9810 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 12Feb2021 at 12:30 PM, as a single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient's medical history included hypothyroidism and known allergies: onions. Concomitant medications included levothyroxine sodium and vitamin b complex (B-COMPLEX). The patient did not receive any other vaccine in four weeks. The patient was diagnosed with COVID prior vaccination. The patient was tested for COVID post vaccination. The patient reported that she felt great yesterday. On 14Feb2021 at 4:15, she awoke feeling dizzy today, tried to sleep and had crazy dreams. When she tried to make the bed, she had a whoosh of dizziness and fell on the bed. Bent over to tie her shes, stood up and started to walk like she just got off the gravitron at the fair and would have hit the floor if the wall wasn't in her way. Tried again with the same result. Gave up and went back to bed after 3 advil. Slept for 5 hours. She still had a bear of a headache and just took 3 more advil and a warm shower. She could walk now, but stull felt like she should report. The patient did not receive treatment for feeling dizzy. The patient underwent lab tests and procedures included COVID (nasal swab) with negative result on 05Feb2021. Outcome of the events was recovering.  Follow-up attempts completed. No further information expected.
A consumer report has been received. The report concerns a 23 year old, Female consumer, who had been receiving Nasal FLUMIST Quadrivalent (Intranasal), 0.2 Millilitres. The patient experienced fever, body ache and chills which started during 2007. The patient recovered from fever, body ache and chills on an unspecified date. The reporter's description of the event(s) was as follows: Unknown. The report was considered to be non-serious.
Symptoms onset within hours of receiving vaccine, complained of: ache at shot site, arthralgias, malaise, fatigue, ?fever/chills (temp not checked), lymph nodes tender and swollen, nausea, vomiting x1, missed work 3 days.
Knee Pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Knee Pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included Knee replacement.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) UNK dosage form. In May 2021, the patient experienced ARTHRALGIA (Knee Pain). At the time of the report, ARTHRALGIA (Knee Pain) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant And treatment medication information was not provided.    Reporter did not allow further contact
Presyncope occurred the morning after receiving the vaccine. I did not actually faint, but when I got out of bed in the morning and walked across the house I suddenly had ringing in ears, started sweating profusely, felt lightheaded and felt like I was going to faint. This lasted for at least a couple minutes.   I'd received the vaccine at 9:10am on 4/14. The first side effects started around 8:15pm and were along the lines of what I expected: body aches, low fever, fatigue, chills. Overnight, despite the fatigue, I had trouble sleeping due to heart palpitations and intermittently feeling too hot or too cold, and eventually I had a headache. All night, I was falling asleep and waking up a little while later.  At around 6:30am on 4/15, after sleeping poorly, my headache had gotten bad enough that I decided to take acetaminophen. I had not previously taken any medicine leading up to the vaccine or after getting the shot. I got out of bed and walked across the house, and that's when the presyncope came. Feeling very faint, I sat down, took the acetaminophen, and waited for the feeling to pass.   Once the feeling did pass, I started to feel better pretty quickly, which may have been the medicine working, and then I was able to sleep for a few hours. A slight fever came back over the course of the day, I took a couple more small doses of acetaminophen as needed, and then on 4/16 I woke up feeling fine.
TINGLING AND NUMBNESS ON LEFT SIDE OF FACE; CHILLS; FEVER; HEADACHE; FATIGUE; This spontaneous report received from a patient concerned a 41 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, expiry: UNKNOWN) dose was not reported, administered on 21-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 21-MAR-2021, the subject experienced tingling and numbness on left side of face. On 21-MAR-2021, the subject experienced chills. On 21-MAR-2021, the subject experienced fever. On 21-MAR-2021, the subject experienced headache. On 21-MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, fever, and headache on MAR-2021, and had not recovered from tingling and numbness on left side of face, and fatigue. This report was non-serious.
BODY ACHES; NO SLEEP; CHILLS; SERIOUS FEVER; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 10-APR-2021, the subject experienced body aches. On 10-APR-2021, the subject experienced no sleep. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced serious fever. On 10-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, chills, serious fever, body aches and no sleep was not reported. This report was non-serious.
This spontaneous report was received from a medical assistant and refers to a 15-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 02-FEB-2016, the patient was vaccinated with a dose of improperly stored GARDASIL 9 (lot # L027282, expiration date: 21-SEP-2017; dose and route of administration were not provided). The vaccine underwent a temperature excursion of either +1 or -1 degrees Celsius for 255.5 total cumulative hours, which was detected by a data logger. There was no previous temperature excursion. No adverse effects were reported. This is one of several hours received from the same reporter. Additional information is not expected, as all required information has been received.
expired vaccine used; Patients received vaccines that went through excursions twice; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Patients received vaccines that went through excursions twice) and EXPIRED PRODUCT ADMINISTERED (expired vaccine used) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-May-2021, the patient experienced PRODUCT STORAGE ERROR (Patients received vaccines that went through excursions twice). On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). On 03-Sep-2021, PRODUCT STORAGE ERROR (Patients received vaccines that went through excursions twice) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication use was unknown Treatment information was unknown
Temp                headache Body Aches Dizziness Chills earache sore throat
PPSV23 administered less than a year after the administration of PCV 13; This initial spontaneous report (split from legal case MARRS # 2008USA010988) was received from an other health professional and refers to a 68-year-old female patient. The patient's medical history included white blood cell count increased, herpes zoster, and pain. Her historical vaccines included influenza virus vaccine (unspecified), zoster vaccine live (ZOSTAVAX), and diphtheria toxoid (+) tetanus toxoid. The patient's concurrent conditions included Janus kinase 2 mutation and myeloproliferative neoplasm.  On 23-MAR-2015, the patient was vaccinated with pneumococcal 4 6b 9v 14 18c 19f 23f conj vaccine (crm197) (PREVNAR), 0.5 mL in the left deltoid, lot # L13524, expiration date reported as 01-SEP-2016, for prophylaxis (strength and route of administration not provided).  On 10-MAR-2016, she was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) prefilled syringe, 0.5 mL in the right deltoid, lot # L040181, expiration date reported as 18-AUG-2017 and confirmed to be valid (strength, route of administration not provided) for prophylaxis (inappropriate schedule of product administration, as according to the Centers for Disease Control and Prevention guidelines, the patients of or above 65 years of age should receive a dose of 23-valent pneumococcal vaccine at least 1 year after a dose of 13-valent pneumococcal vaccine; herein, it was less than a year).  This is one of two reports concerning the same patient. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: L040181; expirationdate: 18-AUG-2017; deviceage and unit: 0 ; operatorofdevice: Health Care Professional; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2102USA005522: US-009507513-2008USA010988: